Dominari Holdings And 2 Other Stocks Under $3 Insiders Are Buying
Dominari Holdings And 2 Other Stocks Under $3 Insiders Are Buying
内部人士正在买入Dominari Holdings和其他2只低于3美元的股票
The Dow Jones index closed lower by over 400 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
道琼斯指数周三收盘下跌400多点。当内部人士购买或出售股票时，这表明他们对公司前景的信心或担忧。对细价股感兴趣的投资者和交易者可以将此视为他们整体投资或交易决策的一个因素。
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
以下是近期一些值得注意的细价股内幕交易。欲了解更多，请查看 本辛加的内幕交易 平台。
Dominari Holdings
多米纳里控股
- The Trade: Dominari Holdings Inc (NASDAQ:DOMH) President Kyle Michael Wool acquired a total of 8,500 shares an average price of $2.99. To acquire these shares, it cost around $25,390.
- What's Happening: On April 1, Dominari Holdings posted a narrower quarterly loss.
- What Dominari Holdings Does: Dominari Holdings Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development.
- 交易：多明纳里控股公司（纳斯达克股票代码：DOMH）总裁凯尔·迈克尔·伍尔 共收购了8,500股股票 平均价格为2.99美元。收购这些股票的成本约为25,390美元。
- 发生了什么：4月1日，多明纳里控股公布的季度亏损有所收窄。
- Dominari Holdings的所作所为：Dominari Holdings Inc是一家生物技术公司，正在开发多元化的小分子抗癌和抗病毒疗法产品组合。
BioRestorative Therapies
生物修复疗法
- The Trade: BioRestorative Therapies Inc (NASDAQ:BRTX) Director, VP of Research and Development Francisco Silva acquired a total of 8,308 shares at at an average price of $1.23. To acquire these shares, it cost around $10,229.
- What's Happening: On April 8, BioRestorative Therapies partnered with Galen Patient Recruitment to accelerate completion of enrollment in Phase 2 trial of BRTX-100 in chronic lumbar disc disease.
- What BioRestorative Therapies Does: BioRestorative Therapies Inc is a biotechnology company based in the United States.
- 贸易：生物修复疗法公司（纳斯达克股票代码：BRTX）董事、研发副总裁弗朗西斯科·席尔瓦 共收购了8,308股股票 平均价格为1.23美元。收购这些股票的成本约为10,229美元。
- 发生了什么：4月8日，BioRestorative Therapies与Galen Patient Recruitment合作，加速完成慢性腰椎间盘疾病 BRTX-100 二期试验的注册工作。
- 生物修复疗法的作用：生物修复疗法公司是一家总部位于美国的生物技术公司。
Lion Copper and Gold
狮子铜和金
- The Trade: Lion Copper and Gold Corp (OTC:LCGMF) Director Tony L Alford acquired a total of 5,072,683 shares at an average price of $0.06. The insider spent around $309,296 to buy those shares.
- What's Happening: The company's stock gained around 6% over the past month.
- What Lion Copper and Gold Does: Lion Copper and Gold Corp is a Canadian mineral exploration company that is engaged in the acquisition, exploration, and development of copper projects in Nevada, Alaska, and Montana in the United States and British Columbia, Canada.
- 贸易：Lion Copper and Gold Corp（场外交易代码：LCGMF）董事托尼·奥尔福德 共收购了5,072,683股股票 平均价格为0.06美元。知情人士花费了约309,296美元购买了这些股票。
- 发生了什么：该公司的股票在过去一个月中上涨了约6％。
- Lion Copper and Gold 做什么：Lion Copper and Gold Corp 是一家加拿大矿产勘探公司，在美国内华达州、阿拉斯加州和蒙大拿州以及加拿大不列颠哥伦比亚省从事铜项目的收购、勘探和开发。
Don't forget to check out our premarket coverage here
别忘了在这里查看我们的上市前报道